Paul Parren
129Patents
16h-index
146Co-inventors
89Inventor score
Filing activity: Oct 17, 2003 → May 6, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7829673B2 | Antibodies against CD38 for treatment of multiple myeloma | Physics | 84 | Active |
| US9150663B2 | Heterodimeric antibody Fc-containing proteins and methods for production thereof | Chemistry; Metallurgy | 79 | Active |
| US7563441B2 | Anti-P-selectin antibodies | Emerging Cross-Sectional Technologies | 64 | Expired |
| US7501496B1 | Anti-OX40L antibodies | Chemistry; Metallurgy | 58 | Expired |
| US7438907B2 | Human monoclonal antibodies against CD25 | Physics | 35 | Expired |
| US9085625B2 | Antibody variants having modifications in the constant region | Chemistry; Metallurgy | 34 | Active |
| US10344050B2 | Production of heterodimeric proteins | Chemistry; Metallurgy | 33 | Active |
| US9212230B2 | Bispecific antibodies and methods for production thereof | Chemistry; Metallurgy | 32 | Active |
| US7282568B2 | Human monoclonal antibodies against interleukin 8 (IL-8) | Chemistry; Metallurgy | 30 | Expired |
| US10597464B2 | Heterodimeric antibody Fc-containing proteins and methods for production thereof | Chemistry; Metallurgy | 29 | Active |
| US9040050B2 | Combination treatment of CD38-expressing tumors | Chemistry; Metallurgy | 28 | Active |
| US10590206B2 | Inert format | Chemistry; Metallurgy | 23 | Active |
| US7850962B2 | Human monoclonal antibodies against CD20 | Chemistry; Metallurgy | 20 | Expired |
| US9102733B2 | Anti-OX40L antibodies | Chemistry; Metallurgy | 20 | Active |
| US7868141B2 | Anti-OX40L antibodies | Chemistry; Metallurgy | 19 | Active |
| US8529902B2 | Human monoclonal antibodies against CD20 | Chemistry; Metallurgy | 16 | Active |
| US9714294B2 | Monoclonal antibodies against HER2 epitope | Chemistry; Metallurgy | 16 | Active |
| US10465006B2 | Humanized or chimeric CD3 antibodies | Physics | 15 | Active |
| US9862769B2 | Monoclonal antibodies against HER2 | Chemistry; Metallurgy | 14 | Active |
| US10906991B2 | Bispecific antibodies and methods for production thereof | Chemistry; Metallurgy | 14 | Active |
| US10407501B2 | Humanized or chimeric CD3 antibodies | Physics | 13 | Active |
| US10364285B2 | Antibodies for the treatment of synucleinopathy | Physics | 12 | Active |
| US9168314B2 | Human antibody drug conjugates against tissue factor | Chemistry; Metallurgy | 12 | Active |
| US10358483B2 | Antibodies for the treatment of synucleinopathy | Physics | 12 | Active |
| US10358484B2 | Antibodies for the treatment of synucleinopathy | Physics | 12 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.